Evidence map›Paper›PMID 30952999›Full record

ReviewMucosal immunology2019

Emerging roles of bile acids in mucosal immunity and inflammation.

Mei Lan Chen, Kiyoshi Takeda, Mark S Sundrud

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Mucosal immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed, 4 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 4 syntheses or guidelines pooled it, 287 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Mei Lan ChenDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL, 33458, USA.
Kiyoshi TakedaDepartment of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
Mark S SundrudDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL, 33458, USA. msundrud@scripps.edu.
Scripps Research Institute · USOsaka University · JP

Funding

Gene Regulation as a Foundation for Autoimmune Disease PreventionU01AI130830 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI WEIRAUCH, MATTHEW TYSON · 2017 to 2021
$7.2M
Bile acid-dependent T cell regulation in the intestineR01AI143821 · NIAID · UNIVERSITY OF FLORIDA · PI SUNDRUD, MARK SCOTT · 2019 to 2023
$2.2M
NIAID NIH HHS R01 AI143821NIAID NIH HHS U01 AI130830
6 · The paper itself

Abstract

Bile acids are cholesterol-derived surfactants that circulate actively between the liver and ileum and that are classically recognized for emulsifying dietary lipids to facilitate absorption. More recent studies, however, have revealed new functions of bile acids; as pleotropic signaling metabolites that regulate diverse metabolic and inflammatory pathways in multiple cell types and tissues through dynamic interactions with both germline-encoded host receptors and the microbiota. Accordingly, perturbed bile acid circulation and/or metabolism is now implicated in the pathogenesis of cholestatic liver diseases, metabolic syndrome, colon cancer, and inflammatory bowel diseases (IBDs). Here, we discuss the three-dimensional interplay between bile acids, the microbiota, and the mucosal immune system, focusing on the mechanisms that regulate intestinal homeostasis and inflammation. Although the functions of bile acids in mucosal immune regulation are only beginning to be appreciated, targeting bile acids and their cellular receptors has already proven an important area of new drug discovery.

Indexed as

Immunity, MucosalAnimalsBile Acids and SaltsBiomarkersEnergy MetabolismEnterohepatic CirculationGastroenteritisGastrointestinal MicrobiomeHumansInflammatory Bowel DiseasesIntestinal MucosaMetabolic Networks and PathwaysReceptors, Cytoplasmic and NuclearSignal TransductionBile Acids and SaltsBiomarkersReceptors, Cytoplasmic and Nuclear

Identifiers

PMID30952999
OpenAlexW2935676311

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.